These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 8764124
1. Ablation of colorectal xenografts with combined radioimmunotherapy and tumor blood flow-modifying agents. Pedley RB, Boden JA, Boden R, Boxer GM, Flynn AA, Keep PA, Begent RH. Cancer Res; 1996 Jul 15; 56(14):3293-300. PubMed ID: 8764124 [Abstract] [Full Text] [Related]
2. Enhancement of antibody-directed enzyme prodrug therapy in colorectal xenografts by an antivascular agent. Pedley RB, Sharma SK, Boxer GM, Boden R, Stribbling SM, Davies L, Springer CJ, Begent RH. Cancer Res; 1999 Aug 15; 59(16):3998-4003. PubMed ID: 10463598 [Abstract] [Full Text] [Related]
11. Combined radioimmunotherapy and radiotherapy of human colon carcinoma grafted in nude mice. Buchegger F, Rojas A, Delaloye AB, Vogel CA, Mirimanoff RO, Coucke P, Sun LQ, Raimondi S, Denekamp J, Pèlgrin A. Cancer Res; 1995 Jan 01; 55(1):83-9. PubMed ID: 7805046 [Abstract] [Full Text] [Related]
12. Combined radioimmunotherapy and chemotherapy of human colon carcinoma grafted in nude mice, advantages and limitations. Chalandon Y, Mach JP, Pèlegrin A, Folli S, Buchegger F. Anticancer Res; 1992 Jan 01; 12(4):1131-9. PubMed ID: 1503403 [Abstract] [Full Text] [Related]
16. [Influence of combination of low dosage 131I-labeled anti-carcinoembryonic antigen antibody C50 and 5-fluorouracil on tumor growth of colorectal cancer xenografts in nude mice]. Zheng CX, Zhan WH, Cai SR, He YL, Lin ZJ. Ai Zheng; 2003 Apr 01; 22(4):354-7. PubMed ID: 12703987 [Abstract] [Full Text] [Related]
17. Radioimmunotherapy of colorectal cancer in small volume disease and in an adjuvant setting: preclinical evaluation in comparison to equitoxic chemotherapy and initial results of an ongoing phase-I/II clinical trial. Behr TM, Memtsoudis S, Vougioukas V, Liersch T, Gratz S, Schmidt F, Lorf T, Post S, Wörmann B, Hiddemann W, Ringe B, Becker W. Anticancer Res; 1999 Apr 01; 19(4A):2427-32. PubMed ID: 10470170 [Abstract] [Full Text] [Related]
18. Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy. Seshadri M, Spernyak JA, Mazurchuk R, Camacho SH, Oseroff AR, Cheney RT, Bellnier DA. Clin Cancer Res; 2005 Jun 01; 11(11):4241-50. PubMed ID: 15930363 [Abstract] [Full Text] [Related]
19. A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies. Wong JYC, Chu DZ, Yamauchi DM, Williams LE, Liu A, Wilczynski S, Wu AM, Shively JE, Doroshow JH, Raubitschek AA. Clin Cancer Res; 2000 Oct 01; 6(10):3855-63. PubMed ID: 11051230 [Abstract] [Full Text] [Related]
20. Toxicity and efficacy of radioimmunotherapy in carcinoembryonic antigen-producing medullary thyroid cancer xenograft: comparison of iodine 131-labeled F(ab')2 and pretargeted bivalent hapten and evaluation of repeated injections. Kraeber-Bodéré F, Faivre-Chauvet A, Saï-Maurel C, Campion L, Fiche M, Gautherot E, Le Boterff J, Barbet J, Chatal JF, Thédrez P. Clin Cancer Res; 1999 Oct 01; 5(10 Suppl):3183s-3189s. PubMed ID: 10541362 [Abstract] [Full Text] [Related] Page: [Next] [New Search]